IDEXX LABORATORIES INC /DE (IDXX) valuation

Share price $565.93 · Close 2026-04-24

Price-to-Earnings

P/E · Trailing Diluted
43.27×
P/E history →

Price-to-Free-Cash-Flow

P/FCF · Trailing
43.38×
P/FCF history →

Free-Cash-Flow Yield

FCF Yield · Trailing
2.31%
FCF Yield history →

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing
28.28×
EV/EBITDA history →

Price-to-Sales

P/S · Trailing
10.48×
P/S history →

Price-to-Book

P/B · Latest filing
28.10×
P/B history →

Expectations investing: what does the price imply?

Growth stretched +18pp above source

Rappaport-style reverse-DCF. We start from the current market price ($565.93 × 79.7M shares = $45.11B market cap, $45.51B enterprise value) and solve for the operating path that would justify it.

To reconcile today's price with a plausible scenario, the model lands on:

  • Year-1 revenue growth: 26.7%
    Source is analyst consensus of 8.7%; the scenario bumped Y1 by +18.0pp to reconcile.
  • Target EBIT margin (Y10): 37.1%
    Scenario lands above the 3-yr max of 31.6% (starting 31.6%, ending 37.1%).
  • High-growth plateau: 5 years
    Stretched from the 3-year tier default to 5 — the default couldn't reconcile with today's price.

at or below the reference above the reference outside the historical band

Where the PV comes from
Y1–3
+3%
Y4–10
+13%
Terminal
+83%

Share of the total PV the model has assigned to each window. The further out a cash flow sits, the harder it is to estimate — so readers can weigh how much of the scenario rests on the near, plateau, and post-horizon periods.

Facts · FY2025 (2025-12-31)

Share price
$565.93
Diluted shares
79.7M
Total debt
$578.2M
Cash & equivalents
$180.1M
Revenue
$4.30B
EBIT (GAAP)
$1.36B
EBIT margin (GAAP)
31.6%
Operating cash flow
$1.18B
CapEx
$124.7M
Observed YoY growth
10.4%
Analyst current-FY growth
8.7%
Analyst next-FY growth
8.6%
3-year revenue CAGR
8.5%

Assumptions

Initial revenue growth
8.7%
from analyst consensus
Year-2 growth
8.6%
from analyst next-FY consensus
Starting EBIT margin
31.6%
from latest FY EBIT margin (GAAP)
Tax rate
20.0%
from 3-year median of EffectiveTaxRate
Starting ROIC
40.0% (capped from 54.3% raw)
NOPAT₀ ÷ invested capital, capped at 40.0%

Constants

Horizon
10 years
WACC
9.0%
Terminal growth
2.5%
Terminal ROIC
11.0%

Yearly projection

Year Revenue Growth EBIT Margin NOPAT ROIC Reinvestment FCF Discount PV of FCF
1 $5.45B 26.7% $1.75B 32.2% $1.40B 37.1% $847.8M $554.7M 0.917 $508.9M
2 $6.91B 26.6% $2.26B 32.7% $1.81B 34.2% $1.18B $625.2M 0.842 $526.2M
3 $8.75B 26.6% $2.91B 33.2% $2.33B 31.3% $1.66B $665.7M 0.772 $514.0M
4 $11.08B 26.6% $3.74B 33.8% $3.00B 28.4% $2.35B $640.9M 0.708 $454.0M
5 $14.03B 26.6% $4.82B 34.3% $3.85B 25.5% $3.37B $483.4M 0.650 $314.2M
6 $17.09B 21.8% $5.96B 34.9% $4.77B 22.6% $4.05B $717.4M 0.596 $427.8M
7 $19.99B 17.0% $7.09B 35.4% $5.67B 19.7% $4.56B $1.11B 0.547 $606.8M
8 $22.42B 12.2% $8.07B 36.0% $6.46B 16.8% $4.69B $1.77B 0.502 $887.2M
9 $24.07B 7.3% $8.79B 36.5% $7.04B 13.9% $4.17B $2.87B 0.460 $1.32B
10 $24.67B 2.5% $9.15B 37.1% $7.32B 11.0% $2.58B $4.74B 0.422 $2.00B
Sum of PV of FCF (years 1-10) $7.56B

Terminal value

NOPATN+1
$7.50B
ReinvestmentN+1
$1.66B
FCFN+1
$5.84B
Terminal value (undiscounted)
$89.84B
PV of terminal value
$37.95B
Gordon-growth: TV = FCFN+1 ÷ (WACC − g) = $5.84B ÷ (9.0% − 2.5%).

Equity bridge

PV of operating FCF $7.56B
+ PV of terminal value $37.95B
= Enterprise value $45.51B
− Total debt $578.2M
+ Cash & equivalents $180.1M
= Equity value $45.11B
÷ Diluted shares 79.7M
= DCF PV / share $565.93
Market price $565.93
Reconciliation delta +0.0% (≈ 0 by construction)
Full calculation trail Click to expand — every number on this page derived step by step.

1 · Enterprise-value target (what the DCF must match)

Market cap   = price × diluted shares
             = $565.93 × 79.7M
             = $45.11B

EV target    = market cap + total debt − cash & equivalents
             = $45.11B + $578.2M − $180.1M
             = $45.51B
            

2 · Starting NOPAT (base year 0)

GAAP EBIT          = $1.36B   (31.6% of revenue)
× (1 − tax rate)  = × (1 − 20.0%) = × 0.8000
= NOPAT₀            = $1.09B
            

3 · Invested capital & starting ROIC

Invested capital = total debt + book equity − cash
                 = $578.2M + $1.61B − $180.1M
                 = $2.00B

Raw ROIC₀        = NOPAT₀ / Invested capital
                 = $1.09B / $2.00B
                 = 54.3%
Cap applied    = min(raw, 40.0%)   (buyback-shrunk IC inflates raw NOPAT/IC past 40%; capping prevents the DCF from modelling infinite return on capital)
ROIC₀ used       = 40.0%
            

4 · Growth path construction

Source       = analyst consensus: Y1 = 8.7%, Y2 = 8.6%
Clamp        = [2.5%, 60%] (no sub-terminal or 60%+ starts)
Plateau rate = 8.6% (Y2 — held from year 2 through end of plateau)
Tier         = 3 years (rule: plateau rate < 15% → 3y, < 25% → 5y, else 7y)
Solver ext.  = 5 years (solver extended to reconcile the DCF with the current price)
Plateau      = 5 years
Fade         = linear from effective Y2 to terminal 2.5% across the remaining 5 years

Effective Y1 growth after solver bumps = 26.7%
Effective Y2 growth after solver bumps = 26.6%
Growth by year:
  Y1 = 26.7%
  Y2 = 26.6%
  Y3 = 26.6%
  Y4 = 26.6%
  Y5 = 26.6%
  Y6 = 21.8%
  Y7 = 17.0%
  Y8 = 12.2%
  Y9 = 7.3%
  Y10 = 2.5%
            

5 · Margin path construction

Starting margin (Y0) = 31.6%   (source: latest FY EBIT margin (GAAP))
Target margin (Y10)  = 37.1%   (solver output, normal band)
Year-t margin        = starting + (target − starting) × (t / 10)
Margin by year:
  Y1 = 32.2%
  Y2 = 32.7%
  Y3 = 33.2%
  Y4 = 33.8%
  Y5 = 34.3%
  Y6 = 34.9%
  Y7 = 35.4%
  Y8 = 36.0%
  Y9 = 36.5%
  Y10 = 37.1%
            

6 · ROIC path construction

The capex heuristic compares latest-period CapEx ($124.7M) against the Normalized CapEx (3-yr mean) of $126.4M — mean of the last three annual CapEx values. When the latest is above 1.4× that mean and CapEx is at least 5% of revenue, we treat the filer as capital-intensive and mid-investment, hold ROIC flat for a 5-year harvest phase, and only then fade to terminal ROIC. The 3-yr mean does not feed the DCF directly — it only gates this flag.

Capex-heuristic inactive (latest CapEx 0.99× the 3-yr mean of $126.4M — below the 1.4× / 5%-of-revenue gates).
Fade from Y1: ROIC_t = ROIC₀ + (ROIC_terminal − ROIC₀) × (t / 10)
ROIC₀ = 40.0%; ROIC_terminal = 11.0%

ROIC by year:
  Y1 = 37.1%
  Y2 = 34.2%
  Y3 = 31.3%
  Y4 = 28.4%
  Y5 = 25.5%
  Y6 = 22.6%
  Y7 = 19.7%
  Y8 = 16.8%
  Y9 = 13.9%
  Y10 = 11.0%
            

7 · Solver iterations

Each row is one bisection attempt. The solver sweeps Y1 growth bumps 0pp → +20pp across the plateau ladder inside the normal margin bracket, then — if nothing reconciles — repeats the same sweep in a widened margin band ([-10%, 80%]). The first feasible attempt is the one the page uses. If no combination reconciles, the page shows the attempt whose PV sits closest to the target EV so both levers are balanced.

# Phase Plateau Y1 bump Solved margin PV(EV) vs target Feasible?
1 normal 3y +0pp 37.9% $19.84B −56.4% no
2 normal 3y +2pp 37.9% $21.44B −52.9% no
3 normal 3y +4pp 37.9% $23.18B −49.1% no
4 normal 3y +6pp 37.9% $25.07B −44.9% no
5 normal 3y +8pp 37.9% $27.11B −40.4% no
6 normal 3y +10pp 37.9% $29.33B −35.6% no
7 normal 3y +12pp 37.9% $31.73B −30.3% no
8 normal 3y +14pp 37.9% $34.32B −24.6% no
9 normal 3y +16pp 37.9% $37.13B −18.4% no
10 normal 3y +18pp 37.9% $40.16B −11.8% no
11 normal 3y +20pp 37.9% $43.43B −4.6% no
12 normal 5y +0pp 37.9% $20.50B −55.0% no
13 normal 5y +2pp 37.9% $22.40B −50.8% no
14 normal 5y +4pp 37.9% $24.50B −46.2% no
15 normal 5y +6pp 37.9% $26.81B −41.1% no
16 normal 5y +8pp 37.9% $29.35B −35.5% no
17 normal 5y +10pp 37.9% $32.14B −29.4% no
18 normal 5y +12pp 37.9% $35.20B −22.7% no
19 normal 5y +14pp 37.9% $38.55B −15.3% no
20 normal 5y +16pp 37.9% $42.22B −7.2% no
21 normal 5y +18pp 37.1% $45.51B +0.0% yes ✓

8 · Terminal value derivation

NOPAT_{N+1}         = NOPAT_{10} × (1 + g_terminal)
                    = $7.32B × (1 + 2.5%)
                    = $7.50B

ΔNOPAT              = NOPAT_{N+1} − NOPAT_{10}
                    = $183.0M
Reinvestment_{N+1}  = ΔNOPAT / ROIC_terminal
                    = $183.0M / 11.0%
                    = $1.66B

FCF_{N+1}           = NOPAT_{N+1} − Reinvestment_{N+1}
                    = $7.50B − $1.66B
                    = $5.84B

Terminal value (TV) = FCF_{N+1} / (WACC − g_terminal)
                    = $5.84B / (9.0% − 2.5%)
                    = $89.84B

PV(TV)              = TV / (1 + WACC)^10
                    = $89.84B / 2.367
                    = $37.95B
            

9 · Reconciliation check (DCF PV vs. the market)

This isn't a fair value — it's the inverse check. The solver built the scenario so that DCF PV reproduces the current enterprise value; if the normal bracket worked the delta below is ~0 by construction. A non-zero delta only appears when the solver fell through to the widened margin band.

Σ PV(FCF_1..10) = $7.56B
+ PV(TV)          = $37.95B
= Enterprise value = $45.51B   (≈ EV target $45.51B by construction)
− Total debt      = $578.2M
+ Cash            = $180.1M
= Equity value    = $45.11B
÷ Diluted shares  = 79.7M
= DCF PV / share  = $565.93

Market price      = $565.93
Reconciliation Δ  = +0.0%   (≈ 0 by construction — the solver anchored on this price)
            
Open this scenario in the calculator →
Every input above is pre-filled; the calculator auto-runs and lets you override any assumption.

Every rule above — growth-source priority, plateau tiers, compound cap, solver ladder, flag colours — is documented on the expectations scenario methodology.

What these ratios mean & how they're built: see the valuation ratios glossary on the company-facts methodology page — per-ratio definitions and the exact us-gaap concepts behind each numerator and denominator.

Sources. Denominators come from SEC EDGAR XBRL filings for IDXX (CIK 0000874716); analyst growth forecasts come from analyst consensus. Share price is the latest split-adjusted close from our daily history (live quote as fallback). Per-share denominators are split-adjusted to today's share count.